Switch to
More onapp

How to use scorecard? Learn more

Venmax Drugs and Pharmaceuticals Ltd

VENMAX
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4 cr, stock is ranked 4,709
Low RiskStock is 0.05x as volatile as Nifty
9.210.43 (+4.90%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹4 cr, stock is ranked 4,709
Low RiskStock is 0.05x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-19.91
PB RatioPB Ratio
-6.43
Dividend YieldDiv. Yield
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venmax Drugs and Pharmaceuticals Limited is an India-based company engaged in manufacturing of pharmaceuticals and drugs. The Company is in the business of trading of bulk drugs, intermediates and biotech products.

Financial TrendFinancial statements 

20212022202320240.351.980.420.20-0.171.840.220.07
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 12, 2024

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Board Meeting 
Announced OnNov 11, 2024

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of Board Meeting | Download

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of Board Meeting | Download

Board Meeting 
Announced OnOct 30, 2024

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 11, 2024 | Download

Venmax Drugs And Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 11, 2024 | Download

See all events